Last10K.com

Alliqua Biomedical, Inc. (ALQA) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

Alliqua Biomedical, Inc.

CIK: 1054274 Ticker: ALQA
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2018
Oct. 26, 2018
Document Information [Line Items]  
Document Type10-Q 
Amendment Flagfalse 
Document Period End DateSep. 30, 2018 
Document Fiscal Year Focus2018 
Document Fiscal Period FocusQ3 
Entity Registrant NameAlliqua BioMedical, Inc. 
Entity Central Index Key0001054274 
Current Fiscal Year End Date--12-31 
Entity Filer CategoryNon-accelerated Filer 
Trading SymbolALQA 
Entity Common Stock, Shares Outstanding 5,005,210
Entity Emerging Growth Companyfalse 
Entity Small Businesstrue 

View differences made from one quarter to another to evaluate Alliqua Biomedical, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alliqua Biomedical, Inc..

Continue

Assess how Alliqua Biomedical, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alliqua Biomedical, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
M & A
Financial
Legal
Revenue
Other
Filter Subcategory:
All
Expense
Product
Debt
Earnings
Other
Inside Alliqua Biomedical, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets [Parenthetical]
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Operations [Parenthetical]
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (Details)
Accrued Expenses And Other Current Liabilities (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details Textual)
Debt
Debt (Details Textual)
Description Of Business And Basis Of Presentation
Description Of Business And Basis Of Presentation (Details 1)
Description Of Business And Basis Of Presentation (Details 2)
Description Of Business And Basis Of Presentation (Details Textual)
Description Of Business And Basis Of Presentation (Details)
Description Of Business And Basis Of Presentation (Policies)
Description Of Business And Basis Of Presentation (Tables)
Fair Value Measurement
Fair Value Measurement (Details 1)
Fair Value Measurement (Details Textual)
Fair Value Measurement (Details)
Fair Value Measurement (Tables)
Going Concern
Going Concern (Details Textual)
Income Taxes
Income Taxes (Details Textual)
Inventory
Inventory (Details)
Inventory (Tables)
Net Loss Per Common Share
Net Loss Per Common Share (Details)
Net Loss Per Common Share (Tables)
Related Party
Related Party (Details Textual)
Revenue Recognition
Stockholders' Equity
Stockholders' Equity (Details 1)
Stockholders' Equity (Details Textual)
Stockholders' Equity (Details)
Stockholders' Equity (Tables)

Material Contracts, Statements, Certifications & more

Alliqua Biomedical, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ALQA
CIK: 1054274
Form Type: 10-Q Quarterly Report
Accession Number: 0001144204-18-055576
Submitted to the SEC: Fri Oct 26 2018 12:10:44 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Sunday, September 30, 2018
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/alqa/0001144204-18-055576.htm